US20050283090A1 - Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals - Google Patents

Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals Download PDF

Info

Publication number
US20050283090A1
US20050283090A1 US11/197,713 US19771305A US2005283090A1 US 20050283090 A1 US20050283090 A1 US 20050283090A1 US 19771305 A US19771305 A US 19771305A US 2005283090 A1 US2005283090 A1 US 2005283090A1
Authority
US
United States
Prior art keywords
signal components
constituent signal
activating
composite signals
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/197,713
Inventor
Martin Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/197,713 priority Critical patent/US20050283090A1/en
Publication of US20050283090A1 publication Critical patent/US20050283090A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7203Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
    • A61B5/7217Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4041Evaluating nerves condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1104Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb induced by stimuli or drugs
    • A61B5/1106Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb induced by stimuli or drugs to assess neuromuscular blockade, e.g. to estimate depth of anaesthesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems

Definitions

  • This invention relates to medical apparatus and methods in general, and more particularly to methods and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • Non-invasive peripheral nerve conduction studies are an important tool in the diagnosis and assessment of neuromuscular injuries and pathologies. Electrical stimulation of a nerve bundle by surface electrodes produces impulses that travel in both the proximal and distal directions. Compound signals can be differentially recorded from the muscle or muscle group that is innervated by the stimulated nerve or from a separate location over the nerve itself. The amplitude and latency (or conduction velocity) of these evoked potential (EP) signals are calculated and used clinically to determine the location of nerve lesions and/or to provide an overall characterization of nerve function. More elaborate analysis of both compound muscle action potentials (CMAPs) and sensory nerve action potentials (SNAPs) have also been investigated and are believed to provide more precise diagnoses and assessment by extracting additional information from the complex signals.
  • CMAPs compound muscle action potentials
  • SNAPs sensory nerve action potentials
  • Stimulus artifacts can be significant enough in magnitude and duration to contaminate the CMAP or SNAP waveform. Signal contamination can be severe, particularly in SNAP recordings where the evoked potential may only be a few microvolts in amplitude.
  • the causes of stimulus artifacts include actual voltage gradients between the recording electrodes, capacitive coupling between the stimulation and detection hardware, and shaping of the stimulus spike by the detection amplifier and analog filters.
  • the magnitude of the artifacts can generally be reduced through careful hardware design, improved skin preparation, and the use of sample-and-hold amplifiers or delay circuits that exclude the stimulus from the recorded action potential trace. In general, however, the stimulus artifacts cannot be completely eliminated from peripheral evoked potential recordings and may dwarf the EP waveform even after implementing these measures.
  • Another aspect that complicates evoked potential analysis is the compound nature of the recorded signals.
  • healthy and diseased tissues are both present and are both activated and recorded.
  • the response of healthy tissue having a normal amplitude and latency, can mask the effect of existing pathology.
  • the healthy and diseased tissues could be measured separately, but this is very difficult in practice.
  • ICA Independent component analysis
  • BSS blind source separation
  • ICA can be performed with no a-priori knowledge of the source signals other than their statistical independence, and no a-priori knowledge about the contribution of each source signal to the recorded mixtures.
  • ICA can also be performed when limited knowledge is available or assumed about either the morphology of the source signals or their contributions to the recordings.
  • FICA fast ICA
  • ICA has been used very promisingly in the separation of multiple sources in scalp recordings of somato-sensory, visual, or auditory evoked potentials (SEP, VEP, AEP) or for source separation and the removal of motion and eye-blink artifacts in passive electroencephalography (EEG).
  • SEP, VEP, AEP auditory evoked potentials
  • EEG passive electroencephalography
  • ICA independent component analysis
  • one object of the present invention is to provide a novel method for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • Yet another object of the present invention is to provide novel apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • ICA independent component analysis
  • ICA independent component analysis
  • the field of evoked, surface-recorded, peripheral neuromuscular electrodiagnostics involves the non-invasive activation and recording of biopotentials directly from nerve and muscle tissues.
  • Surface-recorded, peripheral neuromuscular recordings do not lend themselves to multiple recording site ICA because the dispersive propagation of action potentials through the tissue and the “near-field” nature of the sources lead to violations of the standard assumption of signal congruency among recordings.
  • sources may be considered to be “near-field” when the spatial dimension of the physiologic activity is of the same order of magnitude as the spatial dimensions of the recording electrodes and of the spatial relationship between the electrodes and the active tissue.
  • multiple and different mixtures of the same signal components are generated by successively activating the patient's tissue with different stimuli.
  • the composite signals are generated by applying different levels, or grades, of the same stimuli to the tissue.
  • Such stimuli may comprise electrical stimuli, mechanical stimuli, magnetic stimuli, etc.; electrical stimuli is generally most preferred.
  • SCICA single channel independent component analysis
  • PEP peripheral evoked potential
  • SCICA is a technique that allows ICA to be applied to peripheral evoked potential (PEP) signals.
  • Applications of SCICA to peripheral electrodiagnostics include the removal of stimulation artifacts and the deconvolution of overlapping components. Removal of corrupting artifacts can improve the accuracy of electrodiagnostic parameter estimation. Removal of corrupting artifacts also permits improved diagnostic indices to be identified in the independent component domain, which may more closely represent the underlying electrophysiology.
  • SCICA may also be implemented within a fully automated expert system performing waveform analysis for peripheral neuromuscular diagnostics.
  • FIG. 1 is a multi-panel schematic view illustrating a forward model of compound sensory nerve action potential and stimulus artifact signal generation
  • FIG. 2 is a multi-panel schematic view illustrating the results of Independent Component Estimation on simulated data before and after the addition of corrupting noise;
  • FIG. 3 is a multi-panel schematic view illustrating single channel independent component analysis applied to experimentally recorded peripheral nerve action potential signals
  • FIG. 4 is a multi-panel schematic view illustrating the use of single channel independent component analysis to perform source and artifact classification, and reconstruction of experimentally recorded peripheral nerve action potential signals;
  • FIG. 5 is a schematic view illustrating one preferred mode of implementing the present invention.
  • a linear mixture model assumes that n linear mixtures, x 1 , x 2 , . . . , x n , of n sources, s 1 , s 2 , . . . , s n , are recorded.
  • Each mixing coefficient, a jk defines the amount of component s k that is present in recorded signal x j .
  • both the recorded mixtures and the independent sources may be thought of as multiple (time) samples of a random variable.
  • ICA Independent component analysis
  • FastICA uses a fixed-point iteration algorithm to solve the ICA problem in a rapid and robust manner.
  • the FastICA algorithm is run using random vectors to initialize the IC solutions and a hyperbolic-tangent non-linearity within the optimization routine.
  • the electrically evoked, surface recorded compound sensory nerve action potential is a superposition of components arising from both the underlying biophysical interactions (signal) and directly from the application of an external stimulus pulse (artifact).
  • the basic signal components are single fiber action potentials (SFAPs) and each recorded SNAP is potentially composed of tens of thousands of SFAPs. Single fiber potentials are too small to be detected individually on the surface of the skin due to the physical limitations of modern instrumentation, and it is only through superposition of SFAPs that the SNAP can be recorded.
  • the relationship between the stimulus and the resulting signal is known as the stimulus response curve (SRC).
  • SRC stimulus response curve
  • the SRC for a SNAP is typically a sigmoid with no response for very small stimuli, a saturated or maximal response to large stimuli, and monotonically increasing response magnitude in between those two extremes.
  • SNAP recordings often include artifact components associated with the method of nerve stimulation. Such artifacts are primarily in the region of the stimulus itself but frequently have components lasting many milliseconds, corrupting the action potential signal.
  • the stimulus artifact can have multiple components that come about from the different artifact generating processes. Each component can have not only a different temporal extent, but also its own SRC. Stimulus artifact response curves are believed to be strongly correlated with the stimulus amplitude, duration, or the product of the two (intensity).
  • Sources and mixtures are considered to be random variables for the purposes of ICA so the implicit time dependence can be dropped if each time sample of the mixture is considered to be a single realization of the underlying random variable.
  • c is a random column vector whose elements are the L different mixtures
  • P is an L ⁇ M matrix of mixing coefficients for the individual signal components
  • is a column vector of M independent signal components
  • Q is an L ⁇ N mixing-matrix specific to the contribution of artifact components
  • is a column vector of the N independent artifact components.
  • A is an overall mixing-matrix containing L ⁇ (M+N) coefficients of mixing for both the source and artifact components and s is a vector of source and artifact components.
  • the variables A and s are used in Equation 7 to point out the similarity between this formulation of a SNAP recording and the ICA model of Equations 2 and 3.
  • FIG. 1 This forward model of sensory nerve compound action potential generation is illustrated in FIG. 1 for the simple case of a single source component and a single artifact component.
  • the top panel shows both components as time series plotted with normalized variance.
  • the black trace is a simulated action potential and the gray trace is a simulated stimulus artifact.
  • the center panel of FIG. 1 shows simulated SRCs for each of the signal components. Relative stimulus strength is plotted along the x-axis and response magnitude along the y-axis.
  • the source SRC is plotted in black and the artifact SRC in gray.
  • These curves represent the mixing matrix, A, for this simple example.
  • Circular markers indicate the relative response magnitude for five different stimulus levels. Stimulation at each of these levels will evoke compound signals that are a superposition of the source and artifact components, each scaled by the values of their own SRC.
  • the bottom panel shows the simulated compound signals that result from stimulation at the indicated levels.
  • the model of an electrically evoked, surface recorded, peripheral compound action potential developed above and illustrated in FIG. 1 fits precisely the signal model required for the application of independent component analysis. Instead of using multiple recording sites to generate differing mixtures, this approach uses a single recording site and activates the nerve with different stimuli in order to generate the different mixtures (i.e., the plurality of evoked physiological composite signals needed for the analysis).
  • the assumption made in ICA that each source has a congruent contribution to all mixtures is trivialized through the use of a single electrode pair. It is replaced, however, by a requirement that signal components scale, linearly or non-linearly, with changes in stimulus intensity but do not alter their form. When this requirement is met, source and artifact components of the signals recorded from a single electrode site may be separated through independent components analysis.
  • SCICA single-channel independent component analysis
  • FIG. 2 shows the use of SCICA to estimate the two signal components from the example of FIG. 1 .
  • the FastICA algorithm was applied to the composite data in the bottom panel of FIG. 1 before and after adding corrupting noise to the signals.
  • the top two panels of FIG. 2 show the results of ICA estimation without corrupting noise and the bottom two graphs were generated from noise-added data.
  • Two estimated independent components and their associated mixing vectors are shown. Both sets of results demonstrate estimation of the two original signal components.
  • the fact that the first IC in the top panel and its mixing vector are inverted illustrates the polarity invariance of the IC algorithm. In the case of noisy data, both IC estimates are corrupted but their general shape, and hence the magnitude of their mixing vectors, remains unchanged.
  • the single-channel ICA technique can also be applied to experimentally recorded compound action potential data for artifact removal.
  • An example of this is shown in FIG. 3 .
  • the top panel shows single-channel sensory nerve action potential data recorded from a human subject's middle finger following electrical activation at the wrist.
  • the three traces were activated with different magnitude stimuli and are, therefore, different mixtures of stimulus artifact (the initial decaying signal) and action potential (starting at approximately 2.8 ms) components.
  • ICA independent components
  • Each of the ICs is scaled to represent its contribution to a single trace of the ensemble.
  • the top trace is the first IC returned and its shape clearly associates it with the stimulus artifact.
  • the next two ICs demonstrate characteristics of the action potential source, while the remaining components are mainly noise with minimal contributions to the original signal.
  • the bottom graph shows three reconstructions of data using the estimated ICs.
  • the top reconstruction uses all 6 ICs.
  • the center trace excludes the first (artifact) IC from the sum while the bottom trace is generated from only the artifact IC.
  • This graph clearly shows the ability of SCICA to separate signal and artifact components.
  • the artifact-removed (center) trace is generally highly desirable inasmuch as it yields more accurate measurement of action potential parameters and hence permits more accurate assessment of tissue function.
  • FIG. 3 illustrates an important aspect, specific to artifact removal, which further affects ICAs potential utility when applied within an expert system. Independent components are returned in an unspecified order, with ambiguities in polarity and amplitude. In the reconstruction step, source and artifact ICs must be identified and segregated. The inherent ambiguities of the technique make automated reconstruction a challenge.
  • a human expert identified the first IC as being an artifact component due to the characteristic shape of its time series. Attempts might be made to duplicate this type of reasoning process using artificial neural networks trained to discriminate between artifact and source base on time or frequency domain qualities. This approach would require a substantial developmental dataset for training of the neural network and would assume that the dataset encompassed all possible characteristics of interest.
  • the single-channel ICA model developed for peripheral evoked potentials provides another potentially useful method of automating the identification of source and artifact components. This method, motivated by the center panel of FIG. 1 , is based on the coefficients of mixing returned by ICA. The vertical dotted lines in that plot point out two stimulus levels between which the source contribution changes very little but the artifact contribution continues to grow.
  • This region of plateau in the action potential SRC corresponds to maximal or supramaximal activation of the nerve.
  • Increasing the stimulus magnitude can no longer increase the action potential response because the stimulus is already of sufficient magnitude to activate all of the large nerve fibers (which are the contributors to the recorded sensory nerve action potential).
  • This behavior is also believed to be reflected in the mixing vectors so that, as the stimulus magnitude is increased beyond the maximal level, mixing coefficients of artifact ICs will continue to grow while those of source components stabilize.
  • FIG. 4 Application of this method to experimental action potential recordings is demonstrated in FIG. 4 .
  • the uppermost panel shows a series of five compound action potential waveforms activated by five different intensity stimuli. Each trace in this plot is an average of twelve individual recordings. The magnitude of the physiological source component clearly grows through the first three stimulus levels, but appears to be maximal (stable) for the last three. These action potential data were input to the FastICA algorithm and five independent components were returned. The mixing vectors for those five ICs are shown in the next plot (i.e., the second panel of FIG. 4 ). The x-axis corresponds to the five different stimulus intensities used for data acquisition and the value of each vector (its difference from the dotted line) indicates that IC's contribution to the signal at that stimulus level.
  • the bottom two panels of FIG. 4 show reconstructed source and artifact estimates following automated independent component analysis.
  • the percent change in each independent component's contribution between the last two stimuli was used to classify each component as either source-like or artifact-like.
  • the reconstructed waveforms demonstrate effective removal of stimulus artifacts from the compound signals. The ability to perform automated reconstruction in this way relies on stimulation at and above the maximal level for the SNAP components.
  • FIG. 5 illustrates this embodiment.
  • a variable electric current source 100 is connected to a pair of skin surface stimulation electrodes 101 in such a way that pulsed electrical current stimuli can be delivered to a human subject's median nerve 102 through the surface of the subject's arm 103 .
  • Multiple stimuli, of different stimulus magnitudes, are delivered to the nerve.
  • Each stimulus evokes a compound nerve action potential that travels distally along the median nerve toward the subject's finger 105 .
  • Evoked compound nerve potentials activated in this manner consist of a combination of individual action potentials from multiple nerve fiber sub-populations, each having their own unique bioelectrical characteristics.
  • Varying the magnitude of stimulation results in evoked compound potentials consisting of different mixtures of these same constituent components.
  • Multiple action potentials, resulting from the different magnitude stimuli are recorded at a detection site by a system consisting of detection electrodes 104 and detection circuitry 106 .
  • the recorded compound nerve action potentials 107 consist of different combinations of the same constituent components.
  • a method of mathematical blind source separation, such as independent component analysis, is used to identify the underlying constituent components within the recorded compound potentials. In addition to the underlying components, the amount that each component contributes to the recorded signals can be estimated by the same technique.
  • NC-statTM Nerve Conduction Monitoring System Neuronal Monitoring System
  • CMAPs motor responses
  • SNAPs sensory potentials
  • the battery-powered NC-stat is a handheld device that both activates, using constant current stimuli, and records neuromuscular responses.
  • the NC-stat uses an analog band-pass filter with cutoffs at 1.5 Hz and 3.1 kHz.
  • the gain of the device is variable, with a minimum gain of 55 dB and a maximum of 120 dB. The gain is adjusted automatically for CMAP acquisition in order to make efficient use of the available dynamic range.
  • the NC-stat applies a series of ramped stimuli that increase in intensity and maps the magnitude of the response to those stimuli.
  • the modified device allows for SNAP acquisition by switching the high-pass filter components to produce a pass-band from 160 Hz to 3.1 kHz. SNAPs are acquired, following a series of ramped stimuli, with a fixed gain of 91.4 dB.
  • the modified device also allows for storage of CMAP and SNAP responses to ramped data.
  • the stored waveforms are preferably downloaded to a PC for post-processing and viewing.
  • Both the stimulation and detection electrodes are part of a NC-stat Median BiosensorTM (Neurometrix, Inc., Waltham, Mass.), which is an integrated Ag/AgCl sensor array fabricated on a flexible substrate.
  • the biosensor is placed on the wrist following preparation of the skin with an alcohol and pumice electrode preparation pad (Professional Disposables, Inc., Orangeburg, N.Y., Cat. No. B59800).
  • the stimulating cathode is located approximately 3 cm from the distal wrist crease on the ventral portion of the wrist, directly over the median nerve.
  • the differential detection electrodes are also located proximal to the hand on the medial and lateral surfaces of the wrist.
  • the reference electrode is located directly distal to the stimulating cathode very close to the wrist crease.
  • Antidromic median nerve sensory responses are recorded from ring electrodes around the third digit.
  • the proximal detection electrode is located at the first interphalangeal joint and the second detection electrode is 2.5 to 3 cm distal to that site.
  • the stimulating electrodes and the detection reference electrode on the NC-stat Median Biosensor are used in the same capacity for sensory signal acquisition.
  • the NC-stat can deliver current-controlled, square-wave stimuli with a driving voltage of up to 200 V.
  • the ramped stimuli are preferably delivered in a progression intended to generate a monotonically increasing response from the nerve.
  • the ramped stimuli are preferably delivered so that at least the smallest stimulus, and in some cases the smallest 2 or 3 stimuli, will be sub-threshold and produce no discernable motor or sensory response.
  • the input electronics are shunted to avoid saturation of the amplifiers by the stimulus pulse and to reduce the amplitude and duration of stimulus artifacts.
  • Data is acquired at a rate of 10 kHz for 12.8 ms beginning at the onset of the stimulus.
  • the acquired data is digitized with 10-bit precision over a 10 V dynamic range.
  • the acquired data is analyzed using independent component analysis (ICA), preferably using a freely available FastICA package for MATLAB.
  • ICA independent component analysis
  • FastICA uses a fixed-point iteration algorithm to solve the ICA problem in a rapid and robust manner. Principle components analysis is used to reduce the data dimension. Data dimensions from 1 to 6 were investigated. The number of estimated ICs was always equal to the reduced dimension of the data.
  • the FastICA algorithm was run using random vectors to initialize the IC solutions and a hyperbolic-tangent non-linearity within the optimization routine. A maximum of 2500 iterations were allowed for the algorithm to converge to each IC solution. If the algorithm failed to converge, up to two additional solution attempts were made with re-initialized IC solutions.
  • the present invention may be practiced using other blind source separation techniques.
  • blind source separation techniques such as artificial neural networks, Bayesian blind source separation, Time-Frequency Based Blind Source Separation, Blind Source Separation by Sparse Decomposition, Frequency Domain Blind Source Separation, Blind Source Separation Based on the Characteristic Function, etc.
  • the invention may be practiced in plural form so as to improve the accuracy of identifying the constituent signal components. More particularly, in this form of the invention, activation is effected so as to generate at least two distinct composite signals, the composite signals can be recorded at a first anatomical site X, and those recordings processed so as to identify the constituent signal components; and activation is effected so as to generate at least two distinct composite signals, the composite signals can be recorded at a second anatomical site Y, and those recordings processed so as to identify the constituent signal components; and then the results of these two independent derivations may be further processed, in ways well known in the art of signal processing, so as to improve the accuracy of identifying the constituent signal components. If desired, the responses recorded at the two anatomical sites may result from the same activation event.

Abstract

A novel application of independent component analysis (ICA) to data acquired by a single sensor. The technique exploits the unique relationship between multiple physiologic (source) and electronic (artifact) components in surface recorded sensory nerve action potential (SNAP) waveforms that are evoked by different activating magnitudes. A forward model of the SNAP is developed and used to test the approach on a simplified data simulation. The method is applied to experimental data and shown to be effective at separating artifact and source components and reconstructing artifact-free traces. A method of automated reconstruction for use within an expert system is also disclosed.

Description

    REFERENCE TO PENDING PRIOR PATENT APPLICATION
  • This patent application claims benefit of pending prior U.S. Provisional Patent Application Ser. No. 60/298,831, filed Jun. 18, 2001 by Martin D. Wells for METHODS FOR EXTRACTING OR SEPARATING MULTIPLE EVOKED PHYSIOLOGICAL SIGNAL COMPONENTS FROM RECORDINGS CONSISTING OF THEIR MIXTURES (Attorney's Docket No. NEURO-3 PROV), which patent application is hereby incorporated herein by reference.
  • FIELD OF THE INVENTION
  • This invention relates to medical apparatus and methods in general, and more particularly to methods and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • BACKGROUND OF THE INVENTION
  • Non-invasive peripheral nerve conduction studies (NCS) are an important tool in the diagnosis and assessment of neuromuscular injuries and pathologies. Electrical stimulation of a nerve bundle by surface electrodes produces impulses that travel in both the proximal and distal directions. Compound signals can be differentially recorded from the muscle or muscle group that is innervated by the stimulated nerve or from a separate location over the nerve itself. The amplitude and latency (or conduction velocity) of these evoked potential (EP) signals are calculated and used clinically to determine the location of nerve lesions and/or to provide an overall characterization of nerve function. More elaborate analysis of both compound muscle action potentials (CMAPs) and sensory nerve action potentials (SNAPs) have also been investigated and are believed to provide more precise diagnoses and assessment by extracting additional information from the complex signals.
  • Large artifacts due to the electrical stimuli often appear in surface EP traces. Stimulus artifacts can be significant enough in magnitude and duration to contaminate the CMAP or SNAP waveform. Signal contamination can be severe, particularly in SNAP recordings where the evoked potential may only be a few microvolts in amplitude. The causes of stimulus artifacts include actual voltage gradients between the recording electrodes, capacitive coupling between the stimulation and detection hardware, and shaping of the stimulus spike by the detection amplifier and analog filters. The magnitude of the artifacts can generally be reduced through careful hardware design, improved skin preparation, and the use of sample-and-hold amplifiers or delay circuits that exclude the stimulus from the recorded action potential trace. In general, however, the stimulus artifacts cannot be completely eliminated from peripheral evoked potential recordings and may dwarf the EP waveform even after implementing these measures.
  • Several methods of post-processing to remove stimulus artifacts from EP recordings have been investigated and documented. Inverse filtering to counteract the effects of the detection amplifier, fitting of an artifact to a parameterized function, estimation and subtraction of an artifact from a separate recording, a sub-threshold stimulus or a second stimulus pulse during the refractory period, and non-linear adaptive filtering techniques have all been used. While these methods have proven effective and useful, none are universally applicable and the search for new methods for stimulus artifact removal continues.
  • Another aspect that complicates evoked potential analysis is the compound nature of the recorded signals. Often, healthy and diseased tissues are both present and are both activated and recorded. The response of healthy tissue, having a normal amplitude and latency, can mask the effect of existing pathology. Ideally, the healthy and diseased tissues could be measured separately, but this is very difficult in practice. Alternatively, it would be useful to be able to separate the healthy and diseases responses from compound signals that contain both.
  • Independent component analysis (ICA) is a statistical analysis method that has applications in telecommunications, image processing, and biomedical signal analysis. ICA identifies and extracts the contributions of different, non-Gaussian sources given multiple recordings that are linear mixtures of those contributions. The mixtures may be of multiple sources of interest, in which case ICA allows tracking of the amplitude and latency of each separated source, or they may include unwanted signals such as artifacts that can, after being identified with ICA, be removed from the recordings. Often referred to as a method of blind source separation (BSS), ICA can be performed with no a-priori knowledge of the source signals other than their statistical independence, and no a-priori knowledge about the contribution of each source signal to the recorded mixtures. ICA can also be performed when limited knowledge is available or assumed about either the morphology of the source signals or their contributions to the recordings. Several ICA algorithms have been recently developed, including a fast ICA (FICA) Matlab package that is freely available on the World Wide Web.
  • In biomedical signal analysis, ICA has been used very promisingly in the separation of multiple sources in scalp recordings of somato-sensory, visual, or auditory evoked potentials (SEP, VEP, AEP) or for source separation and the removal of motion and eye-blink artifacts in passive electroencephalography (EEG). These applications lend themselves to ICA because they involve numerous detection electrodes recording combinations of sources from a relatively large distance. The effects of source propagation and of dissimilar filtering by the intervening tissues are neglected for this far-field recording situation and all sources are assumed to contribute an identical, but scaled, component to each recording.
  • This is not usually the case for peripheral EPs, which are recorded in closer proximity to a larger, more coherent group of sources. Different electrode locations over an activated muscle will produce CMAPs that differ in shape and temporal extent due to the active propagation of the generating sources and their near-field relationship to the detection electrodes. Similarly, even closely spaced detection sites along a nerve will see SNAPs that have different latencies and durations due to propagation of the sources past the electrodes and temporal dispersion among the individual action potentials that compose the compound SNAPs.
  • While independent component analysis (ICA) appears to be a very useful tool for blind source separation and removal of contaminating artifacts from cortical evoked potential and EEG recordings, spatially separated peripheral compound muscle and sensory nerve action potentials do not fit the model of linear mixtures normally required for ICA.
  • SUMMARY OF THE INVENTION
  • As a result, one object of the present invention is to provide a novel method for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • And another object of the present invention is to provide novel apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals.
  • As noted above, while independent component analysis (ICA) appears to be a very useful tool for blind source separation and removal of contaminating artifacts from cortical evoked potential and EEG recordings, spatially separated peripheral compound muscle and sensory nerve action potentials do not fit the model of linear mixtures normally required for ICA.
  • In accordance with the present invention, it has now been discovered that one way to overcome this problem is to record different linear mixtures of multiple sources from a single recording site. In this case, the contribution from each source is known to have an identical shape and temporal extent in all recordings. Problems associated with the propagation of near-field sources and the differences in intervening tissues, common in multiple site recordings, are eliminated. As a result, independent component analysis (ICA) can be used for blind source separation and the removal of contaminating artifacts from evoked physiological composite signals.
  • More particularly, the field of evoked, surface-recorded, peripheral neuromuscular electrodiagnostics involves the non-invasive activation and recording of biopotentials directly from nerve and muscle tissues. Surface-recorded, peripheral neuromuscular recordings do not lend themselves to multiple recording site ICA because the dispersive propagation of action potentials through the tissue and the “near-field” nature of the sources lead to violations of the standard assumption of signal congruency among recordings. In general, sources may be considered to be “near-field” when the spatial dimension of the physiologic activity is of the same order of magnitude as the spatial dimensions of the recording electrodes and of the spatial relationship between the electrodes and the active tissue. In accordance with the present invention, it has now been discovered that there are certain situations, however, for which multiple traces recorded from the same electrodes can be modeled as mixtures of the same, statistically independent components with different weighting coefficients—the same model that has been used to apply ICA to traces from multiple recording sites. The use of multiple signals from a single sensor obviates the assumption that different sources contribute similar components to each recording but requires a means, other than spatial separation, to generate multiple and different mixtures of the same signal components.
  • In one preferred form of the invention, multiple and different mixtures of the same signal components (i.e., a plurality of evoked physiological composite signals) are generated by successively activating the patient's tissue with different stimuli. And in one particularly preferred form of the invention, the composite signals are generated by applying different levels, or grades, of the same stimuli to the tissue. Such stimuli may comprise electrical stimuli, mechanical stimuli, magnetic stimuli, etc.; electrical stimuli is generally most preferred.
  • The present invention can be described as single channel independent component analysis (SCICA). SCICA is a technique that allows ICA to be applied to peripheral evoked potential (PEP) signals. Applications of SCICA to peripheral electrodiagnostics include the removal of stimulation artifacts and the deconvolution of overlapping components. Removal of corrupting artifacts can improve the accuracy of electrodiagnostic parameter estimation. Removal of corrupting artifacts also permits improved diagnostic indices to be identified in the independent component domain, which may more closely represent the underlying electrophysiology. SCICA may also be implemented within a fully automated expert system performing waveform analysis for peripheral neuromuscular diagnostics.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with accompanying drawings wherein like numbers refer to like parts and further wherein:
  • FIG. 1 is a multi-panel schematic view illustrating a forward model of compound sensory nerve action potential and stimulus artifact signal generation;
  • FIG. 2 is a multi-panel schematic view illustrating the results of Independent Component Estimation on simulated data before and after the addition of corrupting noise;
  • FIG. 3 is a multi-panel schematic view illustrating single channel independent component analysis applied to experimentally recorded peripheral nerve action potential signals;
  • FIG. 4 is a multi-panel schematic view illustrating the use of single channel independent component analysis to perform source and artifact classification, and reconstruction of experimentally recorded peripheral nerve action potential signals; and
  • FIG. 5 is a schematic view illustrating one preferred mode of implementing the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Independent Component Analysis
  • A linear mixture model assumes that n linear mixtures, x1, x2, . . . , xn, of n sources, s1, s2, . . . , sn, are recorded. The resulting signals can each be written as
    x j =a j1 s 1 +a j2 s 2 + . . . +a jn s n, for j=1,2,3, . . . , n.  (1)
    Each mixing coefficient, ajk, defines the amount of component sk that is present in recorded signal xj. While there is no explicit time reference, both the recorded mixtures and the independent sources may be thought of as multiple (time) samples of a random variable. In matrix notation the model can be written as
    x=As  (2)
    where A is the mixing matrix. Both the source components and the mixing matrix are completely unknown. Estimation and extraction of these elements from the recorded signals constitutes blind source separation. Once the (square) mixing matrix has been estimated, its inverse can be calculated and used to extract the source components. This is expressed as
    s=A −1 x=Wx.  (3)
  • Independent component analysis (ICA) relies upon the statistical independence of the source variables, and the fact that they are each distributed in a non-Gaussian manner, to perform blind source separation. Central limit theorems suggest that mixtures of non-Gaussian variables will be distributed in a more Gaussian manner than their components. ICA determines independent components, therefore, by finding directions, in the n-dimensional sample space, for which the Gaussian nature of the marginal (projected) probability density function is minimized. The components of the un-mixing matrix, W, are defined by these directions. While the concept is relatively straightforward, there is wide variation in both the way that “Gaussian-ity” is measured and the manner with which the minimization routine is performed.
  • For this work, a freely available FastICA package for MATLAB (Mathworks, Inc., Natick, Mass.) may be used. FastICA uses a fixed-point iteration algorithm to solve the ICA problem in a rapid and robust manner. The FastICA algorithm is run using random vectors to initialize the IC solutions and a hyperbolic-tangent non-linearity within the optimization routine.
  • Sensory Nerve Action Potentials
  • The electrically evoked, surface recorded compound sensory nerve action potential (SNAP) is a superposition of components arising from both the underlying biophysical interactions (signal) and directly from the application of an external stimulus pulse (artifact). In sensory nerve recordings the basic signal components are single fiber action potentials (SFAPs) and each recorded SNAP is potentially composed of tens of thousands of SFAPs. Single fiber potentials are too small to be detected individually on the surface of the skin due to the physical limitations of modern instrumentation, and it is only through superposition of SFAPs that the SNAP can be recorded. Due to the large number of fibers, the distribution of fiber size and position within the nerve is nearly a continuum and it is therefore quite common to consider populations of fibers, rather than individual fibers, to be the basic unit of excitation. Given this consideration, the contribution from a population of fibers will change in a graded fashion depending on the number of fibers in that population that are activated by a particular stimulus.
  • The relationship between the stimulus and the resulting signal is known as the stimulus response curve (SRC). In general, as the stimulus increases in either amplitude or duration the size of the response also increases. For sensory signals this amounts to an increased contribution from one or more fiber populations. The SRC for a SNAP is typically a sigmoid with no response for very small stimuli, a saturated or maximal response to large stimuli, and monotonically increasing response magnitude in between those two extremes.
  • SNAP recordings often include artifact components associated with the method of nerve stimulation. Such artifacts are primarily in the region of the stimulus itself but frequently have components lasting many milliseconds, corrupting the action potential signal. The stimulus artifact can have multiple components that come about from the different artifact generating processes. Each component can have not only a different temporal extent, but also its own SRC. Stimulus artifact response curves are believed to be strongly correlated with the stimulus amplitude, duration, or the product of the two (intensity).
  • An electrically evoked, surface recorded compound action potential, C, can be modeled as the sum of signal and artifact components, C ( j , t ) = m = 1 M p m ( j ) ϕ m ( t ) + n = 1 N q n ( j ) γ n ( t ) . ( 4 )
    where
      • M is the total number of basis sources (SFAP populations) that potentially contribute to the compound signal,
      • φm is the mth basis source waveform,
      • pm is a coefficient reflecting the amplitude dependence of φm on the stimulus used to evoke C,
      • N is the total number of artifact components that potentially contribute to the signal,
      • γn is the form of the nth basis artifact component,
      • qn is a coefficient reflecting the amplitude dependence of γn on the stimulus used to evoke C,
      • t is an independent variable representing time, and
      • j is an independent variable reflecting the intensity of the applied stimulus pulse—analagous to j in Equation 1.
  • Sources and mixtures are considered to be random variables for the purposes of ICA so the implicit time dependence can be dropped if each time sample of the mixture is considered to be a single realization of the underlying random variable. In this case, the recorded signal can be rewritten as C = m = 1 M p m ϕ m + n = 1 N q n γ n ( 5 )
    In matrix form this equation becomes
    c=Pφ+Qγ  (6)
    where c is a random column vector whose elements are the L different mixtures, P is an L×M matrix of mixing coefficients for the individual signal components, φ is a column vector of M independent signal components, Q is an L×N mixing-matrix specific to the contribution of artifact components, and γ is a column vector of the N independent artifact components. This mathematical structure can be concatenated to yield c = [ P Q ] [ φ γ ] = As . ( 7 )
    In this final formulation, A is an overall mixing-matrix containing L×(M+N) coefficients of mixing for both the source and artifact components and s is a vector of source and artifact components. The variables A and s are used in Equation 7 to point out the similarity between this formulation of a SNAP recording and the ICA model of Equations 2 and 3.
  • This forward model of sensory nerve compound action potential generation is illustrated in FIG. 1 for the simple case of a single source component and a single artifact component. The top panel shows both components as time series plotted with normalized variance. The black trace is a simulated action potential and the gray trace is a simulated stimulus artifact. At each time sample these two waveforms define the component vector, s in Equation 7. The center panel of FIG. 1 shows simulated SRCs for each of the signal components. Relative stimulus strength is plotted along the x-axis and response magnitude along the y-axis. Again, the source SRC is plotted in black and the artifact SRC in gray. These curves represent the mixing matrix, A, for this simple example. Circular markers indicate the relative response magnitude for five different stimulus levels. Stimulation at each of these levels will evoke compound signals that are a superposition of the source and artifact components, each scaled by the values of their own SRC. The bottom panel shows the simulated compound signals that result from stimulation at the indicated levels.
  • The model of an electrically evoked, surface recorded, peripheral compound action potential developed above and illustrated in FIG. 1 fits precisely the signal model required for the application of independent component analysis. Instead of using multiple recording sites to generate differing mixtures, this approach uses a single recording site and activates the nerve with different stimuli in order to generate the different mixtures (i.e., the plurality of evoked physiological composite signals needed for the analysis). The assumption made in ICA that each source has a congruent contribution to all mixtures is trivialized through the use of a single electrode pair. It is replaced, however, by a requirement that signal components scale, linearly or non-linearly, with changes in stimulus intensity but do not alter their form. When this requirement is met, source and artifact components of the signals recorded from a single electrode site may be separated through independent components analysis.
  • Single-Channel ICA
  • Assuming the above model, single-channel independent component analysis (SCICA) can be used for the identification and removal of stimulus artifacts from compound SNAP recordings. Different mixtures of signal and artifact are recorded at a single site by varying the intensity of the activating stimulus. Disparities in the way that signal and artifact sources respond to various stimuli produce an ensemble of mixtures and allow SCICA to separate the artifact components from the action potential components of interest.
  • FIG. 2 shows the use of SCICA to estimate the two signal components from the example of FIG. 1. The FastICA algorithm was applied to the composite data in the bottom panel of FIG. 1 before and after adding corrupting noise to the signals. The top two panels of FIG. 2 show the results of ICA estimation without corrupting noise and the bottom two graphs were generated from noise-added data. Two estimated independent components and their associated mixing vectors (contribution to the original data) are shown. Both sets of results demonstrate estimation of the two original signal components. The fact that the first IC in the top panel and its mixing vector are inverted illustrates the polarity invariance of the IC algorithm. In the case of noisy data, both IC estimates are corrupted but their general shape, and hence the magnitude of their mixing vectors, remains unchanged.
  • The single-channel ICA technique can also be applied to experimentally recorded compound action potential data for artifact removal. An example of this is shown in FIG. 3. The top panel shows single-channel sensory nerve action potential data recorded from a human subject's middle finger following electrical activation at the wrist. The three traces were activated with different magnitude stimuli and are, therefore, different mixtures of stimulus artifact (the initial decaying signal) and action potential (starting at approximately 2.8 ms) components.
  • Applying ICA to such data results in the identification of the independent components (ICs), shown in the second panel. Each of the ICs is scaled to represent its contribution to a single trace of the ensemble. The top trace is the first IC returned and its shape clearly associates it with the stimulus artifact. The next two ICs demonstrate characteristics of the action potential source, while the remaining components are mainly noise with minimal contributions to the original signal. The bottom graph shows three reconstructions of data using the estimated ICs. The top reconstruction uses all 6 ICs. The center trace excludes the first (artifact) IC from the sum while the bottom trace is generated from only the artifact IC. This graph clearly shows the ability of SCICA to separate signal and artifact components. The artifact-removed (center) trace is generally highly desirable inasmuch as it yields more accurate measurement of action potential parameters and hence permits more accurate assessment of tissue function.
  • Automated SCICA
  • The use of ICA within an expert or automated system presents several issues of implementation. Among these are the determination that acquired data is of sufficient quality and fidelity to expect accurate IC estimation, the selection of appropriate data dimension prior to ICA and the appropriate number of ICs to return from the analysis, and selection of algorithm parameters and IC estimate initializations to maximize the probability of convergence on an appropriate solution. These issues apply to any automated application of ICA and must be properly understood before ICA can be an effective tool independent of a human operator.
  • The data of FIG. 3 illustrates an important aspect, specific to artifact removal, which further affects ICAs potential utility when applied within an expert system. Independent components are returned in an unspecified order, with ambiguities in polarity and amplitude. In the reconstruction step, source and artifact ICs must be identified and segregated. The inherent ambiguities of the technique make automated reconstruction a challenge.
  • In the example, a human expert identified the first IC as being an artifact component due to the characteristic shape of its time series. Attempts might be made to duplicate this type of reasoning process using artificial neural networks trained to discriminate between artifact and source base on time or frequency domain qualities. This approach would require a substantial developmental dataset for training of the neural network and would assume that the dataset encompassed all possible characteristics of interest. The single-channel ICA model developed for peripheral evoked potentials provides another potentially useful method of automating the identification of source and artifact components. This method, motivated by the center panel of FIG. 1, is based on the coefficients of mixing returned by ICA. The vertical dotted lines in that plot point out two stimulus levels between which the source contribution changes very little but the artifact contribution continues to grow. This region of plateau in the action potential SRC corresponds to maximal or supramaximal activation of the nerve. Increasing the stimulus magnitude can no longer increase the action potential response because the stimulus is already of sufficient magnitude to activate all of the large nerve fibers (which are the contributors to the recorded sensory nerve action potential). This behavior is also believed to be reflected in the mixing vectors so that, as the stimulus magnitude is increased beyond the maximal level, mixing coefficients of artifact ICs will continue to grow while those of source components stabilize.
  • Application of this method to experimental action potential recordings is demonstrated in FIG. 4. The uppermost panel shows a series of five compound action potential waveforms activated by five different intensity stimuli. Each trace in this plot is an average of twelve individual recordings. The magnitude of the physiological source component clearly grows through the first three stimulus levels, but appears to be maximal (stable) for the last three. These action potential data were input to the FastICA algorithm and five independent components were returned. The mixing vectors for those five ICs are shown in the next plot (i.e., the second panel of FIG. 4). The x-axis corresponds to the five different stimulus intensities used for data acquisition and the value of each vector (its difference from the dotted line) indicates that IC's contribution to the signal at that stimulus level. The plateau effect of reaching a maximal stimulus level is apparent in the first IC mixing vector. Between the fourth and fifth stimuli, the percent change in that vector is quite small. The contribution of the second and third ICs, on the other hand, changes significantly between the fourth and fifth stimuli—indicating that those ICs are closely associated with the artifact component. This measure of association can be used to automatically separate source and artifact ICs.
  • The bottom two panels of FIG. 4 show reconstructed source and artifact estimates following automated independent component analysis. The percent change in each independent component's contribution between the last two stimuli was used to classify each component as either source-like or artifact-like. The reconstructed waveforms demonstrate effective removal of stimulus artifacts from the compound signals. The ability to perform automated reconstruction in this way relies on stimulation at and above the maximal level for the SNAP components.
  • EXAMPLE
  • The preferred embodiment of the present invention provides for the estimation of constituent components of multiple, electrically evoked, peripheral sensory nerve signals. FIG. 5 illustrates this embodiment. A variable electric current source 100 is connected to a pair of skin surface stimulation electrodes 101 in such a way that pulsed electrical current stimuli can be delivered to a human subject's median nerve 102 through the surface of the subject's arm 103. Multiple stimuli, of different stimulus magnitudes, are delivered to the nerve. Each stimulus evokes a compound nerve action potential that travels distally along the median nerve toward the subject's finger 105. Evoked compound nerve potentials activated in this manner consist of a combination of individual action potentials from multiple nerve fiber sub-populations, each having their own unique bioelectrical characteristics. Varying the magnitude of stimulation results in evoked compound potentials consisting of different mixtures of these same constituent components. Multiple action potentials, resulting from the different magnitude stimuli, are recorded at a detection site by a system consisting of detection electrodes 104 and detection circuitry 106. The recorded compound nerve action potentials 107 consist of different combinations of the same constituent components. A method of mathematical blind source separation, such as independent component analysis, is used to identify the underlying constituent components within the recorded compound potentials. In addition to the underlying components, the amount that each component contributes to the recorded signals can be estimated by the same technique.
  • More particularly, surface recordings of electrically evoked compound action potentials are preferably made using an NC-stat™ Nerve Conduction Monitoring System (Neurometrix, Inc., Waltham, Mass.) modified to acquire both motor responses (CMAPs) and sensory potentials (SNAPs). The battery-powered NC-stat is a handheld device that both activates, using constant current stimuli, and records neuromuscular responses. For motor signal recording, the NC-stat uses an analog band-pass filter with cutoffs at 1.5 Hz and 3.1 kHz. The gain of the device is variable, with a minimum gain of 55 dB and a maximum of 120 dB. The gain is adjusted automatically for CMAP acquisition in order to make efficient use of the available dynamic range. As part of a standard nerve conduction test, the NC-stat applies a series of ramped stimuli that increase in intensity and maps the magnitude of the response to those stimuli.
  • The modified device allows for SNAP acquisition by switching the high-pass filter components to produce a pass-band from 160 Hz to 3.1 kHz. SNAPs are acquired, following a series of ramped stimuli, with a fixed gain of 91.4 dB. The modified device also allows for storage of CMAP and SNAP responses to ramped data. The stored waveforms are preferably downloaded to a PC for post-processing and viewing.
  • Motor responses are recorded non-invasively from the hypothenar muscle of the hand following stimulation at the wrist. Both the stimulation and detection electrodes are part of a NC-stat Median Biosensor™ (Neurometrix, Inc., Waltham, Mass.), which is an integrated Ag/AgCl sensor array fabricated on a flexible substrate. The biosensor is placed on the wrist following preparation of the skin with an alcohol and pumice electrode preparation pad (Professional Disposables, Inc., Orangeburg, N.Y., Cat. No. B59800). When the biosensor is in place, the stimulating cathode is located approximately 3 cm from the distal wrist crease on the ventral portion of the wrist, directly over the median nerve. The differential detection electrodes are also located proximal to the hand on the medial and lateral surfaces of the wrist. The reference electrode is located directly distal to the stimulating cathode very close to the wrist crease.
  • Antidromic median nerve sensory responses are recorded from ring electrodes around the third digit. The proximal detection electrode is located at the first interphalangeal joint and the second detection electrode is 2.5 to 3 cm distal to that site. The stimulating electrodes and the detection reference electrode on the NC-stat Median Biosensor are used in the same capacity for sensory signal acquisition. The NC-stat can deliver current-controlled, square-wave stimuli with a driving voltage of up to 200 V. The ramped stimuli are preferably delivered in a progression intended to generate a monotonically increasing response from the nerve. In addition, the ramped stimuli are preferably delivered so that at least the smallest stimulus, and in some cases the smallest 2 or 3 stimuli, will be sub-threshold and produce no discernable motor or sensory response.
  • During the stimulus itself, and for 1.5 ms following stimulus onset, the input electronics are shunted to avoid saturation of the amplifiers by the stimulus pulse and to reduce the amplitude and duration of stimulus artifacts. Data is acquired at a rate of 10 kHz for 12.8 ms beginning at the onset of the stimulus. The acquired data is digitized with 10-bit precision over a 10 V dynamic range.
  • The acquired data is analyzed using independent component analysis (ICA), preferably using a freely available FastICA package for MATLAB. FastICA uses a fixed-point iteration algorithm to solve the ICA problem in a rapid and robust manner. Principle components analysis is used to reduce the data dimension. Data dimensions from 1 to 6 were investigated. The number of estimated ICs was always equal to the reduced dimension of the data. The FastICA algorithm was run using random vectors to initialize the IC solutions and a hyperbolic-tangent non-linearity within the optimization routine. A maximum of 2500 iterations were allowed for the algorithm to converge to each IC solution. If the algorithm failed to converge, up to two additional solution attempts were made with re-initialized IC solutions.
  • CONCLUSION
  • As noted above, surface recorded peripheral nerve signals do not lend themselves to effective analysis by traditional, multi-channel independent components due to the difficulty in recording the same signal at different sites. In accordance with the present invention, a new method has been described and demonstrated, however, that does allow ICA to be utilized on these data. This new method uses different evoking stimuli to produce different mixtures of source and artifact components that can be recorded from a single site. The resulting plurality of evoked physiological composite signals can then be processed using a blind source separation technique (for example, by single-channel independent component analysis) to identify the underlying constituent components within the recorded composite signals and to identify the amount that each component contributes to a composite signal. As a result, signal-contaminating artifacts may be removed from the evoked physiological composite signals, thereby permitting more accurate assessment of tissue function.
  • It should also be appreciated that the present invention may be practiced using other blind source separation techniques. By way of example but not limitation, it is believed that the present invention may be practiced using blind source separation techniques such as artificial neural networks, Bayesian blind source separation, Time-Frequency Based Blind Source Separation, Blind Source Separation by Sparse Decomposition, Frequency Domain Blind Source Separation, Blind Source Separation Based on the Characteristic Function, etc.
  • In addition to the foregoing, it should also be appreciated that the invention may be practiced in plural form so as to improve the accuracy of identifying the constituent signal components. More particularly, in this form of the invention, activation is effected so as to generate at least two distinct composite signals, the composite signals can be recorded at a first anatomical site X, and those recordings processed so as to identify the constituent signal components; and activation is effected so as to generate at least two distinct composite signals, the composite signals can be recorded at a second anatomical site Y, and those recordings processed so as to identify the constituent signal components; and then the results of these two independent derivations may be further processed, in ways well known in the art of signal processing, so as to improve the accuracy of identifying the constituent signal components. If desired, the responses recorded at the two anatomical sites may result from the same activation event.
  • Or it is possible to generate at least two distinct composite signals, record those composite signals at at least two separate anatomical sites, and then process the recorded signals, collectively, using blind source separation techniques so as to determine the constituent signal components.

Claims (49)

1. A method for identifying constituent signal components from a plurality of evoked physiological composite signals, said method comprising:
activating a subject's anatomy so as to generate the plurality of composite signals, wherein at least two of said composite signals comprise distinct mixtures of the same constituent signal components;
recording, at a single anatomical site, the composite signals; and
performing blind source separation on the composite signals so as to identify the constituent signal components.
2. A method according to claim 1 wherein said blind source separation is performed so as to identify the amount that each constituent signal component contributes to the composite signals.
3. A method according to claim 1 wherein said blind source separation is performed using independent component analysis.
4. A method according to claim 1 wherein at least one of the constituent signal components is an evoked neuromuscular response.
5. A method according to claim 4 wherein the evoked neuromuscular response is a compound nerve action potential (CMAP).
6. A method according to claim 4 wherein the evoked neuromuscular response is a sensory nerve action potential (SNAP).
7. A method according to claim 1 wherein at lease one of the constituent signal components is a directly recorded artifact of activating a subject's anatomy.
8. A method according to claim 1 wherein activating a subject's anatomy involves activating neuromuscular tissue.
9. A method according to claim 8 wherein the neuromuscular tissue comprises a peripheral nerve.
10. A method according to claim 1 wherein a subject's anatomy is activated with different levels of the same type of stimuli.
11. A method according to claim 10 wherein the stimuli comprises electrical stimuli.
12. A method according to claim 10 wherein the stimuli comprises mechanical stimuli.
13. A method according to claim 10 wherein the stimuli comprises magnetic stimuli.
14. A method according to claim 1 wherein the method comprises the additional step of removing a constituent signal component from a composite signal so as to yield a calculated composite signal.
15. A method according to claim 14 wherein the removed constituent signal component comprises a directly recorded artifact of activating the subject's anatomy.
16. A method according to claim 1 wherein the method comprises the additional step of removing a plurality of constituent signal components from a composite signal so as to yield a calculated composite signal.
17. A method according to claim 1 wherein the method comprises the additional step of constructing a calculated composite signal from at least one of the identified constituent signal components.
18. A method according to claim 17 wherein said calculated composite signal reduces the contribution of directly recorded artifacts of activating the subject's anatomy vis-à-vis the original composite signal.
19. A method according to claim 1 wherein the method comprises the additional step of relating the identified signal components to their underlying phenomena.
20. A method according to claim 19 wherein the underlying phenomena is anatomical function.
21. A method according to claim 19 wherein the underlying phenomena is an artifact of activating the subject's anatomy.
22. A method according to claim 1 wherein the blind source separation is performed so as to separate out several constituent signal components, each of which results from anatomical function.
23. Apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals, said apparatus comprising:
activating means for activating a subject's anatomy so as to generate the plurality of composite signals, wherein at least two of said composite signals comprise distinct mixtures of the same constituent signal components;
recording means for recording, at a single anatomical site, the composite signals; and
separation means for performing blind source separation on the composite signals so as to identify the constituent signal components.
24. Apparatus according to claim 23 wherein said separation means are adapted to identify the amount that each constituent signal component contributes to the composite signals.
25. Apparatus according to claim 23 wherein said separation means are adapted to use independent component analysis.
26. Apparatus according to claim 23 wherein at least one of the constituent signal components is an evoked neuromuscular response.
27. Apparatus according to claim 26 wherein the evoked neuromuscular response is a compound nerve action potential (CMAP).
28. Apparatus according to claim 26 wherein the evoked neuromuscular response is a sensory nerve action potential (SNAP).
29. Apparatus according to claim 23 wherein at lease one of the constituent signal components is a directly recorded artifact of activating the subject's anatomy.
30. Apparatus according to claim 23 wherein said activating means are adapted to activate neuromuscular tissue.
31. Apparatus according to claim 30 wherein the neuromuscular tissue comprises a peripheral nerve.
32. Apparatus according to claim 23 wherein said activating means are adapted to activate the subject's anatomy with different levels of the same type of stimuli.
33. Apparatus according to claim 32 wherein the stimuli comprises electrical stimuli.
34. Apparatus according to claim 32 wherein the stimuli comprises mechanical stimuli.
35. Apparatus according to claim 32 wherein the stimuli comprises magnetic stimuli.
36. Apparatus according to claim 23 wherein the apparatus comprises removal means for removing a constituent signal component from a composite signal so as to yield a calculated composite signal.
37. Apparatus according to claim 36 wherein the removed constituent signal component comprises a directly recorded artifact of activating the subject's anatomy.
38. Apparatus according to claim 23 wherein the apparatus comprises removal means for removing a plurality of constituent signal components from a composite signal so as to yield a calculated composite signal.
39. Apparatus according to claim 23 wherein the apparatus comprises reconstruction means for constructing a calculated composite signal from at least one of the identified constituent signal components.
40. Apparatus according to claim 39 wherein said
calculated composite signal reduces the contribution of directly recorded artifacts of activating the subject's anatomy vis-a-vis the original composite signals.
41. Apparatus according to claim 23 wherein the apparatus comprises relating means for relating the identified signal components to their underlying phenomena.
42. Apparatus according to claim 41 wherein said relating means comprises a discrimination algorithm running on a computer.
43. Apparatus according to claim 41 wherein the underlying phenomena is anatomical function.
44. Apparatus according to claim 41 wherein the underlying phenomena is an artifact of activating the subject's anatomy.
45. Apparatus according to claim 23 wherein the blind source separation is performed so as to separate out several constituent signal components, each of which results from anatomical function.
46. A method for identifying constituent signal components from a plurality of evoked physiological composite signals, said method comprising:
activating a subject's anatomy so as to generate the plurality of composite signals, wherein at least two of said composite signals comprise distinct mixtures of the same constituent signal components;
recording, at a single anatomical site, the composite signals; and
processing the composite signals so as to identify the constituent signal components.
47. Apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals, said apparatus comprising:
activating means for activating a subject's anatomy so as to generate the plurality of composite signals, wherein at least two of said composite signals comprise distinct mixtures of the same constituent signal components;
recording means for recording, at a single anatomical site, the composite signals; and
processing the composite signals so as to identify the constituent signal components.
48. A method according to claim 1 wherein the subject's anatomy is activated at at least two separate anatomical sites.
49. A method according to claim 23 wherein said activating means activate the subject's anatomy at at least two separate anatomical sites.
US11/197,713 2001-06-18 2005-08-04 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals Abandoned US20050283090A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/197,713 US20050283090A1 (en) 2001-06-18 2005-08-04 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29883101P 2001-06-18 2001-06-18
US10/174,153 US6936012B2 (en) 2001-06-18 2002-06-18 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
US11/197,713 US20050283090A1 (en) 2001-06-18 2005-08-04 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/174,153 Continuation US6936012B2 (en) 2001-06-18 2002-06-18 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Publications (1)

Publication Number Publication Date
US20050283090A1 true US20050283090A1 (en) 2005-12-22

Family

ID=26869926

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/174,153 Expired - Lifetime US6936012B2 (en) 2001-06-18 2002-06-18 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
US11/197,713 Abandoned US20050283090A1 (en) 2001-06-18 2005-08-04 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/174,153 Expired - Lifetime US6936012B2 (en) 2001-06-18 2002-06-18 Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Country Status (1)

Country Link
US (2) US6936012B2 (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050017870A1 (en) * 2003-06-05 2005-01-27 Allison Brendan Z. Communication methods based on brain computer interfaces
US20060287609A1 (en) * 2005-06-01 2006-12-21 Litvak Leonid M Methods and systems for automatically identifying whether a neural recording signal includes a neural response signal
US20080208072A1 (en) * 2004-08-30 2008-08-28 Fadem Kalford C Biopotential Waveform Data Fusion Analysis and Classification Method
US20100145221A1 (en) * 2008-12-08 2010-06-10 Brunnett William C Nerve electrode
US20100145222A1 (en) * 2008-12-08 2010-06-10 Brunnett William C Method and system for monitoring a nerve
US8433395B1 (en) 2009-11-03 2013-04-30 Vivaquant Llc Extraction of cardiac signal data
US8478389B1 (en) 2010-04-23 2013-07-02 VivaQuant, LLC System for processing physiological data
US8543195B1 (en) 2009-11-03 2013-09-24 VivaQuant, LLC ECG sensing with noise filtering
US8632465B1 (en) 2009-11-03 2014-01-21 Vivaquant Llc Physiological signal denoising
US8688202B2 (en) 2009-11-03 2014-04-01 Vivaquant Llc Method and apparatus for identifying cardiac risk
US9008762B2 (en) 2009-11-03 2015-04-14 Vivaquant Llc Method and apparatus for identifying cardiac risk
US9072438B2 (en) 2009-11-03 2015-07-07 Vivaquant Llc Method and apparatus for identifying cardiac risk
US9314181B2 (en) 2009-11-03 2016-04-19 Vivaquant Llc Method and apparatus for detection of heartbeat characteristics
US9339202B2 (en) 2009-11-03 2016-05-17 Vivaquant Llc System for processing physiological data
US9408549B2 (en) 2009-11-03 2016-08-09 Vivaquant Llc Detecting fiducial points in physiological signals
US9414786B1 (en) 2009-11-03 2016-08-16 Vivaquant Llc ECG sensing with noise filtering
US9414758B1 (en) 2011-01-12 2016-08-16 Vivaquant Llc Apparatus, system and methods for sensing and processing physiological signals
US9492096B2 (en) 2009-11-03 2016-11-15 Vivaquant Llc ECG sensing apparatuses, systems and methods
US9706956B2 (en) 2009-11-03 2017-07-18 Vivaquant Llc Method and apparatus for assessing cardiac and/or mental health
WO2018027141A1 (en) * 2016-08-05 2018-02-08 The Regents Of The University Of Colorado, A Body Corporate In-ear sensing systems and methods for biological signal monitoring
US11103145B1 (en) 2017-06-14 2021-08-31 Vivaquant Llc Physiological signal monitoring and apparatus therefor
US11273283B2 (en) 2017-12-31 2022-03-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US11931142B1 (en) 2019-03-19 2024-03-19 VIVAQUANT, Inc Apneic/hypopneic assessment via physiological signals

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936012B2 (en) * 2001-06-18 2005-08-30 Neurometrix, Inc. Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
GB0229473D0 (en) * 2002-12-18 2003-01-22 Qinetiq Ltd Signal separation system and method
GB0309049D0 (en) * 2003-04-22 2003-05-28 Univ Manchester Nervous system monitoring method
US20100010369A1 (en) * 2003-04-22 2010-01-14 The University Of Manchester Nervous system monitoring method
WO2005010677A2 (en) * 2003-07-18 2005-02-03 Cytokinetics, Inc. Characterizing biological stimuli by response curves
WO2005040739A2 (en) * 2003-10-22 2005-05-06 Softmax, Inc. System and method for spectral analysis
JP4485396B2 (en) * 2004-03-27 2010-06-23 三星電子株式会社 Biological signal simultaneous measurement device, control method thereof, and computer-readable recording medium
US9259164B2 (en) 2004-08-30 2016-02-16 Neuronetrix, Inc. Controller for neuromuscular testing
US7424322B2 (en) * 2005-02-03 2008-09-09 Cardinal Health 209, Inc. Method and apparatus for stimulus artifact suppression
CA2544331A1 (en) * 2005-04-20 2006-10-20 Excel-Tech Ltd. Device, method and stimulus unit for testing neuromuscular function
US20070185409A1 (en) * 2005-04-20 2007-08-09 Jianping Wu Method and system for determining an operable stimulus intensity for nerve conduction testing
US20070129771A1 (en) * 2005-04-20 2007-06-07 Kurtz Ronald L Device, method and stimulus unit for testing neuromuscular function
FI119133B (en) * 2005-04-28 2008-07-31 Elekta Ab Method and apparatus for eliminating interference from electromagnetic multichannel measurement
EP3287073A1 (en) 2005-07-01 2018-02-28 Impedimed Limited Monitoring system
AU2006265763B2 (en) 2005-07-01 2012-08-09 Impedimed Limited Monitoring system
JP5208749B2 (en) 2005-10-11 2013-06-12 インペダイムド・リミテッド Hydration status monitoring
US9014798B2 (en) * 2005-10-20 2015-04-21 Neurometrix, Inc. Automated stimulus artifact removal for nerve conduction studies
CA2684324C (en) 2007-04-20 2017-05-30 Impedimed Limited Monitoring system and probe
US20110046505A1 (en) 2007-08-09 2011-02-24 Impedimed Limited Impedance measurement process
EP2328470B1 (en) * 2008-08-29 2019-10-16 Koninklijke Philips N.V. Compensation of motion artifacts in capacitive measurement of electrophysiological signals
JP5643829B2 (en) 2009-10-26 2014-12-17 インぺディメッド リミテッドImpedimed Limited Method and apparatus for use in impedance measurement analysis
EP2501283B1 (en) 2009-11-18 2016-09-21 Impedimed Limited Signal distribution for patient-electrode measurements
US10568559B2 (en) 2011-05-13 2020-02-25 Saluda Medical Pty Ltd Method and apparatus for measurement of neural response
WO2012155189A1 (en) 2011-05-13 2012-11-22 National Ict Australia Ltd Method and apparatus for estimating neural recruitment - f
US9872990B2 (en) 2011-05-13 2018-01-23 Saluda Medical Pty Limited Method and apparatus for application of a neural stimulus
AU2012255671B2 (en) 2011-05-13 2016-10-06 Saluda Medical Pty Limited Method and apparatus for measurement of neural response - a
WO2012155184A1 (en) 2011-05-13 2012-11-22 National Ict Australia Ltd Method and apparatus for measurement of neural response - c
US8700121B2 (en) 2011-12-14 2014-04-15 Intersection Medical, Inc. Devices for determining the relative spatial change in subsurface resistivities across frequencies in tissue
DK2908904T3 (en) 2012-11-06 2020-12-14 Saluda Medical Pty Ltd SYSTEM FOR CONTROLING THE ELECTRICAL CONDITION OF TISSUE
AU2014351064B2 (en) 2013-11-15 2019-07-04 Closed Loop Medical Pty Ltd Monitoring brain neural potentials
AU2014353891B2 (en) 2013-11-22 2020-02-06 Saluda Medical Pty Ltd Method and device for detecting a neural response in a neural measurement
WO2015168735A1 (en) 2014-05-05 2015-11-12 Saluda Medical Pty Ltd Improved neural measurement
DK3171929T3 (en) 2014-07-25 2021-05-25 Saluda Medical Pty Ltd DOSAGE FOR NERVE STIMULATION
WO2016077882A1 (en) 2014-11-17 2016-05-26 Saluda Medical Pty Ltd Method and device for detecting a neural response in neural measurements
US10588698B2 (en) 2014-12-11 2020-03-17 Saluda Medical Pty Ltd Implantable electrode positioning
WO2016090436A1 (en) 2014-12-11 2016-06-16 Saluda Medical Pty Ltd Method and device for feedback control of neural stimulation
AU2016208972B2 (en) 2015-01-19 2021-06-24 Saluda Medical Pty Ltd Method and device for neural implant communication
JP7071121B2 (en) 2015-04-09 2022-05-18 サルーダ・メディカル・ピーティーワイ・リミテッド Estimating the distance between the electrode and the nerve
AU2016273415B2 (en) 2015-05-31 2021-07-15 Closed Loop Medical Pty Ltd Monitoring brain neural activity
WO2016191807A1 (en) 2015-05-31 2016-12-08 Saluda Medical Pty Ltd Brain neurostimulator electrode fitting
JP7204325B2 (en) 2015-06-01 2023-01-16 クローズド・ループ・メディカル・ピーティーワイ・リミテッド motor fiber neuromodulation
CN105640500A (en) * 2015-12-21 2016-06-08 安徽大学 Scanning signal feature extraction method based on independent component analysis and recognition method
EP3439732B1 (en) 2016-04-05 2021-06-02 Saluda Medical Pty Ltd Improved feedback control of neuromodulation
WO2017219096A1 (en) 2016-06-24 2017-12-28 Saluda Medical Pty Ltd Neural stimulation for reduced artefact
US11051737B2 (en) * 2017-05-19 2021-07-06 Ricoh Company, Ltd. Biomagnetic measurement method, biomagnetic measuring device, and biomagnetic measuring system
US11484268B2 (en) * 2018-03-15 2022-11-01 Ricoh Company, Ltd. Biological signal analysis device, biological signal measurement system, and computer-readable medium
US11944820B2 (en) 2018-04-27 2024-04-02 Saluda Medical Pty Ltd Neurostimulation of mixed nerves
CN114364318A (en) * 2019-07-12 2022-04-15 萨鲁达医疗有限公司 Monitoring the quality of a neural recording

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256118A (en) * 1977-07-13 1981-03-17 Biotronik Mess-Und Therapiegerate Gmbh & Co. Apparatus for the detection and recording of uterine activity
US5327902A (en) * 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5383164A (en) * 1993-06-10 1995-01-17 The Salk Institute For Biological Studies Adaptive system for broadband multisignal discrimination in a channel with reverberation
US6266558B1 (en) * 1998-12-01 2001-07-24 Neurometrix, Inc. Apparatus and method for nerve conduction measurements with automatic setting of stimulus intensity
US6544170B1 (en) * 1999-06-21 2003-04-08 Shimadzu Corporation Biosignal measuring method and apparatus
US20030093006A1 (en) * 2001-11-06 2003-05-15 Neurometrix, Inc. Method and apparatus for the detection of neuromuscular disease using disease specific evoked neuromuscular response analysis
US6692444B2 (en) * 1997-07-01 2004-02-17 Neurometrix, Inc. Methods for the assessment of neuromuscular function by F-wave latency
US20040111220A1 (en) * 1999-02-19 2004-06-10 Fox Chase Cancer Center Methods of decomposing complex data
US6882992B1 (en) * 1999-09-02 2005-04-19 Paul J. Werbos Neural networks for intelligent control
US6936012B2 (en) * 2001-06-18 2005-08-30 Neurometrix, Inc. Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002013906A1 (en) * 2000-08-16 2002-02-21 Vanderbilt University Methods and devices for optical stimulation of neural tissues

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256118A (en) * 1977-07-13 1981-03-17 Biotronik Mess-Und Therapiegerate Gmbh & Co. Apparatus for the detection and recording of uterine activity
US5327902A (en) * 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5383164A (en) * 1993-06-10 1995-01-17 The Salk Institute For Biological Studies Adaptive system for broadband multisignal discrimination in a channel with reverberation
US6692444B2 (en) * 1997-07-01 2004-02-17 Neurometrix, Inc. Methods for the assessment of neuromuscular function by F-wave latency
US6266558B1 (en) * 1998-12-01 2001-07-24 Neurometrix, Inc. Apparatus and method for nerve conduction measurements with automatic setting of stimulus intensity
US20040111220A1 (en) * 1999-02-19 2004-06-10 Fox Chase Cancer Center Methods of decomposing complex data
US6544170B1 (en) * 1999-06-21 2003-04-08 Shimadzu Corporation Biosignal measuring method and apparatus
US6882992B1 (en) * 1999-09-02 2005-04-19 Paul J. Werbos Neural networks for intelligent control
US6936012B2 (en) * 2001-06-18 2005-08-30 Neurometrix, Inc. Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
US20030093006A1 (en) * 2001-11-06 2003-05-15 Neurometrix, Inc. Method and apparatus for the detection of neuromuscular disease using disease specific evoked neuromuscular response analysis

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7546158B2 (en) * 2003-06-05 2009-06-09 The Regents Of The University Of California Communication methods based on brain computer interfaces
US20050017870A1 (en) * 2003-06-05 2005-01-27 Allison Brendan Z. Communication methods based on brain computer interfaces
US20080208072A1 (en) * 2004-08-30 2008-08-28 Fadem Kalford C Biopotential Waveform Data Fusion Analysis and Classification Method
US20060287609A1 (en) * 2005-06-01 2006-12-21 Litvak Leonid M Methods and systems for automatically identifying whether a neural recording signal includes a neural response signal
US7818052B2 (en) * 2005-06-01 2010-10-19 Advanced Bionics, Llc Methods and systems for automatically identifying whether a neural recording signal includes a neural response signal
US9084551B2 (en) * 2008-12-08 2015-07-21 Medtronic Xomed, Inc. Method and system for monitoring a nerve
US20100145221A1 (en) * 2008-12-08 2010-06-10 Brunnett William C Nerve electrode
US20100145222A1 (en) * 2008-12-08 2010-06-10 Brunnett William C Method and system for monitoring a nerve
US9931045B2 (en) 2008-12-08 2018-04-03 Medtronic Xomed, Inc. Nerve electrode
US11051736B2 (en) 2008-12-08 2021-07-06 Medtronic Xomed, Inc. Method and system for monitoring a nerve
US8515520B2 (en) 2008-12-08 2013-08-20 Medtronic Xomed, Inc. Nerve electrode
US9579037B2 (en) 2008-12-08 2017-02-28 Medtronic Xomed, Inc. Method and system for monitoring a nerve
US9050007B1 (en) 2009-11-03 2015-06-09 Vivaquant Llc Extraction of cardiac signal data
US9414786B1 (en) 2009-11-03 2016-08-16 Vivaquant Llc ECG sensing with noise filtering
US10231638B2 (en) 2009-11-03 2019-03-19 Vivaquant Llc ECG sensing with noise filtering
US9072438B2 (en) 2009-11-03 2015-07-07 Vivaquant Llc Method and apparatus for identifying cardiac risk
US8688202B2 (en) 2009-11-03 2014-04-01 Vivaquant Llc Method and apparatus for identifying cardiac risk
US9294074B2 (en) 2009-11-03 2016-03-22 Vivaquant Llc Physiological signal denoising
US9314181B2 (en) 2009-11-03 2016-04-19 Vivaquant Llc Method and apparatus for detection of heartbeat characteristics
US9339202B2 (en) 2009-11-03 2016-05-17 Vivaquant Llc System for processing physiological data
US9408549B2 (en) 2009-11-03 2016-08-09 Vivaquant Llc Detecting fiducial points in physiological signals
US9008762B2 (en) 2009-11-03 2015-04-14 Vivaquant Llc Method and apparatus for identifying cardiac risk
US8632465B1 (en) 2009-11-03 2014-01-21 Vivaquant Llc Physiological signal denoising
US9492096B2 (en) 2009-11-03 2016-11-15 Vivaquant Llc ECG sensing apparatuses, systems and methods
US8543195B1 (en) 2009-11-03 2013-09-24 VivaQuant, LLC ECG sensing with noise filtering
US9706956B2 (en) 2009-11-03 2017-07-18 Vivaquant Llc Method and apparatus for assessing cardiac and/or mental health
US9713431B2 (en) 2009-11-03 2017-07-25 Vivaquant Llc Method and apparatus for detection of heartbeat characteristics
US10098561B2 (en) 2009-11-03 2018-10-16 Vivaquant Llc Method and apparatus for detection of heartbeat characteristics
US8433395B1 (en) 2009-11-03 2013-04-30 Vivaquant Llc Extraction of cardiac signal data
US10028706B2 (en) 2009-11-03 2018-07-24 Vivaquant Llc System for processing physiological data
US8478389B1 (en) 2010-04-23 2013-07-02 VivaQuant, LLC System for processing physiological data
US9414758B1 (en) 2011-01-12 2016-08-16 Vivaquant Llc Apparatus, system and methods for sensing and processing physiological signals
WO2018027141A1 (en) * 2016-08-05 2018-02-08 The Regents Of The University Of Colorado, A Body Corporate In-ear sensing systems and methods for biological signal monitoring
US11382561B2 (en) 2016-08-05 2022-07-12 The Regents Of The University Of Colorado, A Body Corporate In-ear sensing systems and methods for biological signal monitoring
US11103145B1 (en) 2017-06-14 2021-08-31 Vivaquant Llc Physiological signal monitoring and apparatus therefor
US11723579B2 (en) 2017-09-19 2023-08-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11273283B2 (en) 2017-12-31 2022-03-15 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US11931142B1 (en) 2019-03-19 2024-03-19 VIVAQUANT, Inc Apneic/hypopneic assessment via physiological signals
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep

Also Published As

Publication number Publication date
US6936012B2 (en) 2005-08-30
US20030032889A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
US6936012B2 (en) Method and apparatus for identifying constituent signal components from a plurality of evoked physiological composite signals
Sadikoglu et al. Electromyogram (EMG) signal detection, classification of EMG signals and diagnosis of neuropathy muscle disease
Turnip et al. Real-time feature extraction of P300 component using adaptive nonlinear principal component analysis
Snyder et al. Independent component analysis of gait-related movement artifact recorded using EEG electrodes during treadmill walking
Tong et al. Quantitative EEG analysis methods and clinical applications
Reaz et al. Techniques of EMG signal analysis: detection, processing, classification and applications
EP0013183B1 (en) Electroencephalographic system for the quantitative description of patient brain states
Wang et al. Revisiting signal processing with spectrogram analysis on EEG, ECG and speech signals
Chen et al. ReMAE: User-friendly toolbox for removing muscle artifacts from EEG
Khan et al. Brain–computer interface for single-trial EEG classification for wrist movement imagery using spatial filtering in the gamma band
RU2627818C1 (en) Method of bionic control of technical devices
Norali et al. Surface electromyography signal processing and application: A review
Pun et al. Brain-computer interaction research at the Computer Vision and Multimedia Laboratory, University of Geneva
Islam et al. Signal artifacts and techniques for artifacts and noise removal
Goen et al. Review of surface electromyogram signals: its analysis and applications
Islam et al. Probability mapping based artifact detection and removal from single-channel EEG signals for brain–computer interface applications
de Freitas et al. EEG artifact correction strategies for online trial-by-trial analysis
Abbaspour et al. Artefacts removal to detect visual evoked potentials in brain computer interface systems
Mesin Inverse modelling to reduce crosstalk in high density surface electromyogram
Qi Algorithms benchmarking for removing EOG artifacts in brain computer interface
Khatter et al. Study of various automatic eeg artifact removal techniques
Thenappan Performance improvement in electroencephalogram signal by using DWT
Naqvi et al. Spectral and spatial feature extraction of electroencephalographic (EEG) data using independent component analysis (ICA)
Rao et al. Lateralized Neural Entropy modulates with Grip Force during Precision Grasping
Richter et al. Biomedical Signals: ECG, EEG

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION